Kenvue's shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held.
Kimberly-Clark said on Monday it will buy Tylenol-maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies in the United States.
Shares of Kenvue were up 18% in premarket tradin... [884 chars]